ING strong in Damrak area as US economy strengthens | Financial

At three o’clock, the AEX is slightly lower at 767.4 points. The AMX falls 0.2% to 1073.2 points.

Most other European stock market indicators also continue to fluctuate around record levels. Britain’s FTSE 100, Germany’s DAX and France’s CAC 40 are gaining 0.1%, 0.2% and 0.5% respectively.

The index futures point to a divided opening of Wall Street at half past three: the Dow is at 0.3% gain, technology stock Nasdaq will open 0.4% lower. On Thursday, the Dow Jones and the Nasdaq index gained 0.8%.

Strong growth

Last month’s job figure in the US, excluding agriculture, added 943,000 jobs. That’s better than widely expected, economists polled by Bloomberg news agency expected about 858,000 additional jobs on average. As a result, unemployment fell from 5.9 to 5.4 percent.

The dollar then strengthened 0.5% against the euro to $1.1782. The yield on the 10-year US Treasury bond briefly rose to 1.3%.

Earlier this week, figures from payslip processor ADP showed that corporate employment growth in July was much slower than expected. Investment strategist Wim Zwanenburg of Stroeve & Lemberger points out that there is a lot of demand for personnel. “But employers can’t always find people.”

“The published profits of all major US companies so far have more than doubled”

Despite the record stock markets, Zwanenburg remains optimistic. “The stock market momentum is very positive, especially thanks to the very good quarterly reports. The published earnings of all major US companies so far have more than doubled. In addition, the order books are well filled and forecasts are regularly adjusted positively.”

The investment strategist sees a possible strong increase in the number of new corona infections as one of the biggest risks. “Vaccination coverage is good in Europe and the US. But that is not the case for other regions, such as Japan, Australia and Africa. We will therefore continue to suffer from the coronavirus.”

Bitcoin is up close to 9% and returning to above $40,000 per coin. Bank ABN Amro reports that it finds crypto coins such as bitcoin unsuitable as a means of payment.

ING leads

At the Dutch main funds, ING with a gain of 2.7% in the lead, on the message that his gain has nearly doubled in the past quarter. The bank also wants to pay out billions to its shareholders after September, both through dividends and through share buybacks.

Broadcaster Randstad benefits from the jobs report with a 1.6% profit. Insurer Aegon is 1.5% higher, ASR in ING follow with around 1.2% price gain.

Just Eat Takeaway rises 1.2%. ABN Amro concludes that the explosive growth of meal delivery will continue after the pandemic. Furthermore, HelloFresh reported that it had many new customers this year who also ordered more often. The German company saw this as a reason to increase its turnover forecast.

Tech is in the window. Especially the suppliers to the chip sector are losing due to profit taking. ASMI, ASML in Iron drops 1.1%, 0.9% and 0.8% respectively.

Among the medium-sized funds, Fagron with a loss of 3.5% at the bottom. This means that the profit that the supplier made to pharmacists on Thursday after its quarterly publication is lost again.

Bank ABN Amro wins 2.4%, metals supplier AMG increases 1.6%.

SBM Offshore yields 0.7%. On Thursday, the service provider to the oil sector was still 9% higher after better-than-expected quarterly figures.

GrandVision, which is acquired by the eyewear group EssilorLuxottica, lost 0.2%. The owner of optical chain Pearl managed to almost recover from the corona crisis in the past quarter and is looking forward to the rest of the year with confidence.

Galapagos wins 0.7%. The biotech company said in its half-year results it is sticking to an expectation that about $600 million in cash will be burned this year. CEO Onno van de Stolpe stays enthusiastic about the potential of the development platform, the capacity to develop drugs and the strength of the teams.

Smallcap CM.com fell 6.5%. Kempen investment bank calls the company that regulates customer message traffic a ‘supersonic grower’, but lowers the advice to keep it after the enormous price rally of recent weeks.

Biopharmaceutical Pharming loss another 0.6%, after having already surrendered more than 4% in response to its quarterly figures on Thursday.

More relevant financial news in your mailbox every morning for free? Sign up here at.

–